Top

Reviews in Endocrine and Metabolic Disorders

Published in:

01-12-2011

Extragonadal actions of chorionic gonadotropin

Authors: Prajna Banerjee, Asgerally T. Fazleabas

Published in: Reviews in Endocrine and Metabolic Disorders | Issue 4/2011

Abstract

The primary embryonic signal in primates is chorionic gonadotropin (CG, designated hCG in humans), that is classically associated with corpus luteum rescue and progesterone production. However, research over the past decade has revealed the presence of the hCG receptor in a variety of extragonadal tissues. Additionally, discoveries of the multiple variants of hCG, namely, native hCG, hyperglycosylated hCG (hyp-hCG) and the β- subunit of the hyperglycosylated hCG (hCG-free β) has established a role for extragonadal actions of hCG. For the initiation and maintenance of pregnancy, hCG mediates multiple placental, uterine and fetal functions. Some of these include development of syncytiotrophoblast cells, mitotic growth and differentiation of the endometrium, localized suppression of the maternal immune system, modulation of uterine morphology and gene expression and coordination of intricate signal transduction between the endometrium. Recurrent pregnancy loss, pre-eclampsia and endometriosis are associated with altered responses of hCG, all of which have a detrimental effect on pregnancy. A role for hyp-hCG in mediating the development of both trophoblastic and non-trophoblastic tumors has also been suggested. Other significant non-gonadal applications of hCG include predicting preeclampsia, determining the risk of Down’s syndrome and gestational trophoblastic disease, along with relaxing myometrial contractility and preventing recurrent miscarriages. Presence of hCG free-β in serum of cancer patients enables its usage as a diagnostic tumor marker. Thus, the extragonadal functions of hCG encompasses a wide spectrum of applications and is an open area for continued investigation.

Muyan M, Boime I. Secretion of chorionic gonadotropin from human trophoblasts. Placenta. 1997;18(4):237–41.PubMedCrossRef

Shi QJ, Lei ZM, Rao CV, Lin J. Novel role of human chorionic gonadotropin in differentiation of human cytotrophoblasts. Endocrinology. 1993;132(3):1387–95.PubMedCrossRef

Gallego MJ, Porayette P, Kaltcheva MM, Bowen RL, Vadakkadath Meethal S, Atwood CS. The pregnancy hormones human chorionic gonadotropin and progesterone induce human embryonic stem cell proliferation and differentiation into neuroectodermal rosettes. Stem Cell Res Ther. 2010;1(4):28.PubMedCrossRef

Rao CV, Lei ZM. The past, present and future of nongonadal LH/hCG actions in reproductive biology and medicine. Mol Cell Endocrinol. 2007;269(1–2):2–8.PubMedCrossRef

Handschuh K, Guibourdenche J, Tsatsaris V, Guesnon M, Laurendeau I, Evain-Brion D, et al. Human chorionic gonadotropin expression in human trophoblasts from early placenta: comparative study between villous and extravillous trophoblastic cells. Placenta. 2007;28(2–3):175–84.PubMedCrossRef

Cole LA. Biological functions of hCG and hCG-related molecules. Reprod Biol Endocrinol. 2010;8:102.PubMedCrossRef

Bahl OP, Carlsen RB, Bellisario R, Swaminathan N. Human chorionic gonadotropin: amino acid sequence of the alpha and beta subunits. Biochem Biophys Res Commun. 1972;48(2):416–22.PubMedCrossRef

Morgan FJ, Birken S, Canfield RE. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem. 1975;250(13):5247–58.PubMed

Elliott MM, Kardana A, Lustbader JW, Cole LA. Carbohydrate and peptide structure of the alpha- and beta-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma. Endocrine. 1997;7(1):15–32.PubMedCrossRef

10.

Valmu L, Alfthan H, Hotakainen K, Birken S, Stenman UH. Site-specific glycan analysis of human chorionic gonadotropin beta-subunit from malignancies and pregnancy by liquid chromatography–electrospray mass spectrometry. Glycobiology. 2006;16(12):1207–18.PubMedCrossRef

11.

McFarland KC, Sprengel R, Phillips HS, Kohler M, Rosemblit N, Nikolics K, et al. Lutropin-choriogonadotropin receptor: an unusual member of the G protein-coupled receptor family. Science (New York, NY). 1989;245(4917):494–9.CrossRef

12.

Cameo P, Srisuparp S, Strakova Z, Fazleabas AT. Chorionic gonadotropin and uterine dialogue in the primate. Reprod Biol Endocrinol. 2004;2:50.PubMedCrossRef

13.

Fazleabas AT, Kim JJ, Strakova Z. Implantation: embryonic signals and the modulation of the uterine environment--a review. Placenta. 2004;25 Suppl A:S26-31.

14.

Strakova Z, Mavrogianis P, Meng X, Hastings JM, Jackson KS, Cameo P, et al. In vivo infusion of interleukin-1beta and chorionic gonadotropin induces endometrial changes that mimic early pregnancy events in the baboon. Endocrinology. 2005;146(9):4097–104.PubMedCrossRef

15.

Cameo P, Szmidt M, Strakova Z, Mavrogianis P, Sharpe-Timms KL, Fazleabas AT. Decidualization regulates the expression of the endometrial chorionic gonadotropin receptor in the primate. Biol Reprod. 2006;75(5):681–9.PubMedCrossRef

16.

Reshef E, Lei ZM, Rao CV, Pridham DD, Chegini N, Luborsky JL. The presence of gonadotropin receptors in nonpregnant human uterus, human placenta, fetal membranes, and decidua. J Clin Endocrinol Metab. 1990;70(2):421–30.PubMedCrossRef

17.

Licht P, von Wolff M, Berkholz A, Wildt L. Evidence for cycle-dependent expression of full-length human chorionic gonadotropin/luteinizing hormone receptor mRNA in human endometrium and decidua. Fertil Steril. 2003;79 Suppl 1:718–23.PubMedCrossRef

18.

Fazleabas AT, Donnelly KM, Srinivasan S, Fortman JD, Miller JB. Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity. Proc Natl Acad Sci U S A. 1999;96(5):2543–8.PubMedCrossRef

19.

Sherwin JR, Sharkey AM, Cameo P, Mavrogianis PM, Catalano RD, Edassery S, et al. Identification of Novel Genes Regulated by Chorionic Gonadotropin in Baboon Endometrium during the Window of Implantation. Endocrinology. 2007;148(2):618–26.PubMedCrossRef

20.

Brosens I, Derwig I, Brosens J, Fusi L, Benagiano G, Pijnenborg R. The enigmatic uterine junctional zone: the missing link between reproductive disorders and major obstetrical disorders? Hum Reprod. 2010;25(3):569–74.PubMedCrossRef

21.

Lovely LP, Fazleabas AT, Fritz MA, McAdams DG, Lessey BA. Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. J Clin Endocrinol Metab. 2005;90(4):2351–6.PubMedCrossRef

22.

Jasinska A, Strakova Z, Szmidt M, Fazleabas AT. Human chorionic gonadotropin and decidualization in vitro inhibits cytochalasin-D-induced apoptosis in cultured endometrial stromal fibroblasts. Endocrinology. 2006;147(9):4112–21.PubMedCrossRef

23.

Yanaihara A, Otsuka Y, Iwasaki S, Koide K, Aida T, Okai T. Comparison in gene expression of secretory human endometrium using laser microdissection. Reprod Biol Endocrinol. 2004;2:66.PubMedCrossRef

24.

Rodgers WH, Matrisian LM, Giudice LC, Dsupin B, Cannon P, Svitek C, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest. 1994;94(3):946–53.PubMedCrossRef

25.

Prast J, Saleh L, Husslein H, Sonderegger S, Helmer H, Knofler M. Human chorionic gonadotropin stimulates trophoblast invasion through extracellularly regulated kinase and AKT signaling. Endocrinology. 2008;149(3):979–87.PubMedCrossRef

26.

Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992;359(6390):76–9.PubMedCrossRef

27.

Licht P, Russu V, Lehmeyer S, Wildt L. Molecular aspects of direct LH/hCG effects on human endometrium–lessons from intrauterine microdialysis in the human female in vivo. Reprod Biol. 2001;1(1):10–9.PubMed

28.

Yue ZP, Yang ZM, Wei P, Li SJ, Wang HB, Tan JH, et al. Leukemia inhibitory factor, leukemia inhibitory factor receptor, and glycoprotein 130 in rhesus monkey uterus during menstrual cycle and early pregnancy. Biol Reprod. 2000;63(2):508–12.PubMedCrossRef

29.

Evans J, Catalano RD, Brown P, Sherwin R, Critchley HO, Fazleabas AT, et al. Prokineticin 1 mediates fetal-maternal dialogue regulating endometrial leukemia inhibitory factor. Faseb J. 2009;23(7):2165–75.PubMedCrossRef

30.

Paiva P, Hannan NJ, Hincks C, Meehan KL, Pruysers E, Dimitriadis E, et al. Human chorionic gonadotrophin regulates FGF2 and other cytokines produced by human endometrial epithelial cells, providing a mechanism for enhancing endometrial receptivity. Hum Reprod. 2011;26(5):1153–62.PubMedCrossRef

31.

Tsampalas M, Gridelet V, Berndt S, Foidart JM, Geenen V, Perrier D'Hauterive S. Human chorionic gonadotropin: a hormone with immunological and angiogenic properties. J Reprod immunol. 2010;85(1):93–8.PubMedCrossRef

32.

Karande AA, Mukhopadhyay D, Jayachandran R, Sundarraj S, Alok A. Mechanism of the immunomodulatory activity of glycodelin. Indian J Physiol Pharmacol. 2005;49(3):271–83.PubMed

33.

Seppala M, Taylor RN, Koistinen H, Koistinen R, Milgrom E. Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev. 2002;23(4):401–30.PubMedCrossRef

34.

Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev. 2001;180:35–48.PubMedCrossRef

35.

Kajihara T, Uchino S, Suzuki M, Itakura A, Brosens JJ, Ishihara O. Human chorionic gonadotropin confers resistance to oxidative stress-induced apoptosis in decidualizing human endometrial stromal cells. Fertil Steril. 2011.

36.

Kane N, Kelly R, Saunders PT, Critchley HO. Proliferation of uterine natural killer cells is induced by human chorionic gonadotropin and mediated via the mannose receptor. Endocrinology. 2009;150(6):2882–8.PubMedCrossRef

37.

Norris W, Nevers T, Sharma S, Kalkunte S. Review: hCG, preeclampsia and regulatory T cells. Placenta. 2011;32 Suppl 2:S182–5.PubMedCrossRef

38.

Sherwin JR, Hastings JM, Jackson KS, Mavrogianis PA, Sharkey AM, Fazleabas AT. The endometrial response to chorionic gonadotropin is blunted in a baboon model of endometriosis. Endocrinology. 2010;151(10):4982–93.PubMedCrossRef

39.

Klemmt PA, Carver JG, Kennedy SH, Koninckx PR, Mardon HJ. Stromal cells from endometriotic lesions and endometrium from women with endometriosis have reduced decidualization capacity. Fertil Steril. 2006;85(3):564–72.PubMedCrossRef

40.

Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, Aojanepong T, et al. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One. 2010;5(4):e10258.PubMedCrossRef

41.

Salker M, Teklenburg G, Molokhia M, Lavery S, Trew G, Aojanepong T, et al. Natural selection of human embryos: impaired decidualization of endometrium disables embryo-maternal interactions and causes recurrent pregnancy loss. PLoS One. 2010;5(4):e10287.PubMedCrossRef

42.

Banerjee P, Sapru K, Strakova Z, Fazleabas AT. Chorionic gonadotropin regulates prostaglandin E synthase via a phosphatidylinositol 3-kinase-extracellular regulatory kinase pathway in a human endometrial epithelial cell line: implications for endometrial responses for embryo implantation. Endocrinology. 2009;150(9):4326–37.PubMedCrossRef

43.

Palaniappan M, Menon KM. Human chorionic gonadotropin stimulates theca-interstitial cell proliferation and cell cycle regulatory proteins by a cAMP-dependent activation of AKT/mTORC1 signaling pathway. Mol Endocrinol. 2010;24(9):1782–93.PubMedCrossRef

44.

Manna PR, Jo Y, Stocco DM. Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling. J Endocrinol. 2007;193(1):53–63.PubMedCrossRef

45.

Hunzicker-Dunn M, Maizels ET. FSH signaling pathways in immature granulosa cells that regulate target gene expression: branching out from protein kinase A. Cell Signal. 2006;18(9):1351–9.PubMedCrossRef

46.

Srisuparp S, Strakova Z, Brudney A, Mukherjee S, Reierstad S, Hunzicker-Dunn M, et al. Signal transduction pathways activated by chorionic gonadotropin in the primate endometrial epithelial cells. Biol Reprod. 2003;68(2):457–64.PubMedCrossRef

47.

Seminara SB, Dipietro MJ, Ramaswamy S, Crowley Jr WF, Plant TM. Continuous human metastin 45–54 infusion desensitizes G protein-coupled receptor 54-induced gonadotropin-releasing hormone release monitored indirectly in the juvenile male Rhesus monkey (Macaca mulatta): a finding with therapeutic implications. Endocrinology. 2006;147(5):2122–6.PubMedCrossRef

48.

Sales KJ, Grant V, Catalano RD, Jabbour HN. Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal crosstalk for embryo implantation. Mol Hum Reprod. 2011;17(1):22–32.PubMedCrossRef

49.

Fazleabas AT, Donnelly KM, Hild-Petito S, Hausermann HM, Verhage HG. Secretory proteins of the baboon (Papio anubis) endometrium: regulation during the menstrual cycle and early pregnancy. Hum Reprod Update. 1997;3(6):553–9.PubMedCrossRef

50.

Fazleabas AT, Donnelly KM, Mavrogianis PA, Verhage HG. Secretory and morphological changes in the baboon (Papio anubis) uterus and placenta during early pregnancy. Biol Reprod. 1993;49(4):695–704.PubMedCrossRef

51.

Kim JJ, Jaffe RC, Fazleabas AT. Insulin-like growth factor binding protein-1 expression in baboon endometrial stromal cells: regulation by filamentous actin and requirement for de novo protein synthesis. Endocrinology. 1999;140(2):997–1004.PubMedCrossRef

52.

Cole LA. The O-linked oligosaccharide structures are striking different on pregnancy and choriocarcinoma HCG. J Clin Endocrinol Metab. 1987;65(4):811–3.PubMedCrossRef

53.

Kovalevskaya G, Kakuma T, Schlatterer J, O’Connor JF. Hyperglycosylated HCG expression in pregnancy: cellular origin and clinical applications. Mol Cell Endocrinol. 2007;260–262:237–43.PubMedCrossRef

54.

Guibourdenche J, Handschuh K, Tsatsaris V, Gerbaud P, Leguy MC, Muller F, et al. Hyperglycosylated hCG is a marker of early human trophoblast invasion. J Clin Endocrinol Metab. 2010;95(10):E240–4.PubMedCrossRef

55.

Cole LA, Dai D, Butler SA, Leslie KK, Kohorn EI. Gestational trophoblastic diseases: 1. Pathophysiology of hyperglycosylated hCG. Gynecol Oncol. 2006;102(2):145–50.PubMedCrossRef

56.

Hamada AL, Nakabayashi K, Sato A, Kiyoshi K, Takamatsu Y, Laoag-Fernandez JB, et al. Transfection of antisense chorionic gonadotropin beta gene into choriocarcinoma cells suppresses the cell proliferation and induces apoptosis. J Clin Endocrinol Metab. 2005;90(8):4873–9.PubMedCrossRef

57.

Tarrade A, Lai Kuen R, Malassine A, Tricottet V, Blain P, Vidaud M, et al. Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta. Laboratory investigation. J Tech Methods Pathol. 2001;81(9):1199–211.

58.

Staun-Ram E, Shalev E. Human trophoblast function during the implantation process. Reprod Biol Endocrinol. 2005;3:56.PubMedCrossRef

59.

Vuorela P, Hatva E, Lymboussaki A, Kaipainen A, Joukov V, Persico MG, et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta. Biol Reprod. 1997;56(2):489–94.PubMedCrossRef

60.

Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab. 1996;81(8):3112–8.PubMedCrossRef

61.

Cole LA, Khanlian SA, Kohorn EI. Evolution of the human brain, chorionic gonadotropin and hemochorial implantation of the placenta: insights into origins of pregnancy failures, preeclampsia and choriocarcinoma. J Reprod Med. 2008;53(8):549–57.PubMed

62.

Acevedo HF, Tong JY, Hartsock RJ. Human chorionic gonadotropin-beta subunit gene expression in cultured human fetal and cancer cells of different types and origins. Cancer. 1995;76(8):1467–75.PubMedCrossRef

63.

Acevedo HF, Hartsock RJ. Metastatic phenotype correlates with high expression of membrane-associated complete beta-human chorionic gonadotropin in vivo. Cancer. 1996;78(11):2388–99.PubMedCrossRef

64.

Acevedo HF, Hartsock RJ, Maroon JC. Detection of membrane-associated human chorionic gonadotropin and its subunits on human cultured cancer cells of the nervous system. Cancer Detect Prev. 1997;21(4):295–303.PubMed

65.

Li D, Wen X, Ghali L, Al-Shalabi FM, Docherty SM, Purkis P, et al. hCG beta expression by cervical squamous carcinoma–in vivo histological association with tumour invasion and apoptosis. Histopathology. 2008;53(2):147–55.PubMedCrossRef

66.

Iles RK, Lee CL, Oliver RT, Chard T. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder. Clin Endocrinol (Oxf). 1990;33(3):355–64.CrossRef

67.

Iles RK, Purkis PE, Whitehead PC, Oliver RT, Leigh I, Chard T. Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine ‘normal’ and malignant epithelial cells. Br J Cancer. 1990;61(5):663–6.PubMedCrossRef

68.

Butler SA, Ikram MS, Mathieu S, Iles RK. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer. 2000;82(9):1553–6.PubMedCrossRef

69.

Cosgrove DE, Campain JA, Cox GS. Chorionic gonadotropin synthesis by human tumor cell lines: examination of subunit accumulation, steady-state levels of mRNA, and gene structure. Biochim Biophys Acta. 1989;1007(1):44–54.PubMed

70.

Iles RK. Ectopic hCGbeta expression by epithelial cancer: malignant behaviour, metastasis and inhibition of tumor cell apoptosis. Mol Cell Endocrinol. 2007;260–262:264–70.PubMedCrossRef

71.

Cole LA, Khanlian SA, Muller CY, Giddings A, Kohorn E, Berkowitz R. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors. Gynecol Oncol. 2006;102(2):160–4.PubMedCrossRef

72.

Cole LA, Tanaka A, Kim GS, Park SY, Koh MW, Schwartz PE, et al. Beta-core fragment (beta-core/UGF/UGP), a tumor marker: a 7-year report. Gynecol Oncol. 1996;60(2):264–70.PubMedCrossRef

73.

Moutzouris G, Yannopoulos D, Barbatis C, Zaharof A, Theodorou C. Is beta-human chorionic gonadotrophin production by transitional cell carcinoma of the bladder a marker of aggressive disease and resistance to radiotherapy? Br J Urol. 1993;72(6):907–9.PubMedCrossRef

74.

Delves PJ, Iles RK, Roitt IM, Lund T. Designing a new generation of anti-hCG vaccines for cancer therapy. Mol Cell Endocrinol. 2007;260–262:276–81.PubMedCrossRef

75.

Moulton HM, Yoshihara PH, Mason DH, Iversen PL, Triozzi PL. Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival. Clin Cancer Res. 2002;8(7):2044–51.PubMed

76.

Arends J. Radioimmunoassay of urinary human chorionic gonadotrophin. Acta Endocrinol (Copenh). 1971;66(4):611–26.

77.

Cole LA. Human chorionic gonadotropin and associated molecules. Expert Rev Mol Diagn. 2009;9(1):51–73.PubMedCrossRef

78.

Cole LA, Khanlian SA, Sutton JM, Davies S, Stephens ND. Hyperglycosylated hCG (invasive trophoblast antigen, ITA) a key antigen for early pregnancy detection. Clin Biochem. 2003;36(8):647–55.PubMedCrossRef

79.

Butler SA, Khanlian SA, Cole LA. Detection of early pregnancy forms of human chorionic gonadotropin by home pregnancy test devices. Clin Chem. 2001;47(12):2131–6.PubMed

80.

Bjercke S, Tanbo T, Dale PO, Morkrid L, Abyholm T. Human chorionic gonadotrophin concentrations in early pregnancy after in-vitro fertilization. Hum Reprod. 1999;14(6):1642–6.PubMedCrossRef

81.

Sasaki Y, Ladner DG, Cole LA. Hyperglycosylated human chorionic gonadotropin and the source of pregnancy failures. Fertil Steril. 2008;89(6):1781–6.PubMedCrossRef

82.

Kovalevskaya G, Birken S, Kakuma T, Ozaki N, Sauer M, Lindheim S, et al. Differential expression of human chorionic gonadotropin (hCG) glycosylation isoforms in failing and continuing pregnancies: preliminary characterization of the hyperglycosylated hCG epitope. J Endocrinol. 2002;172(3):497–506.PubMedCrossRef

83.

Birken S, Kovalevskaya G, O’Connor J. Immunochemical measurement of early pregnancy isoforms of HCG: potential applications to fertility research, prenatal diagnosis, and cancer. Arch Med Res. 2001;32(6):635–43.PubMedCrossRef

84.

O’Connor JF, Ellish N, Kakuma T, Schlatterer J, Kovalevskaya G. Differential urinary gonadotrophin profiles in early pregnancy and early pregnancy loss. Prenat Diagn. 1998;18(12):1232–40.PubMedCrossRef

85.

Carp HJ. Recurrent miscarriage and hCG supplementation: a review and metaanalysis. Gynecol Endocrinol. 2010;26(10):712–6.PubMedCrossRef

86.

Ticconi C, Piccione E, Belmonte A, Rao ChV. HCG–A new kid on the block in prematurity prevention. J Matern Fetal Neonatal Med. 2006;19(11):687–92.PubMedCrossRef

87.

Kurtzman JT, Spinnato JA, Goldsmith LJ, Zimmerman MJ, Klem M, Lei ZM, et al. Human chorionic gonadotropin exhibits potent inhibition of preterm delivery in a small animal model. Am J Obstet Gynecol. 1999;181(4):853–7.PubMedCrossRef

88.

Angioni S, Spedicato M, Rizzo A, Cosola C, Mutinati M, Minoia G et al. In vitro activity of human chorionic gonadotropin (hCG) on myometrium contractility. Gynecol Endocrinol. 2011.

89.

Scott JR, Pattison N. Human chorionic gonadotrophin for recurrent miscarriage. Cochrane Database Syst Rev. 2000(2):CD000101.

90.

Qureshi NS. Treatment options for threatened miscarriage. Maturitas. 2009;65 Suppl 1:S35–41.PubMedCrossRef

91.

Devaseelan P, Fogarty PP, Regan L. Human chorionic gonadotrophin for threatened miscarriage. Cochrane Database Syst Rev. 2010(5):CD007422.

92.

Muller CY, Cole LA. The quagmire of hCG and hCG testing in gynecologic oncology. Gynecol Oncol. 2009;112(3):663–72.PubMedCrossRef

93.

Cole LA. hCG and hyperglycosylated hCG in the establishment and evolution of hemochorial placentation. J Reprod Immunol. 2009;82(2):112–8.PubMedCrossRef

94.

Cole LA, Butler SA, Khanlian SA, Giddings A, Muller CY, Seckl MJ, et al. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia. Gynecol Oncol. 2006;102(2):151–9.PubMedCrossRef

95.

Seckl MJ, Sebire NJ, Berkowitz RS. Gestational trophoblastic disease. Lancet. 2010;376(9742):717–29.PubMedCrossRef

96.

Cole LA, Shahabi S, Oz UA, Bahado-Singh RO, Mahoney MJ. Hyperglycosylated human chorionic gonadotropin (invasive trophoblast antigen) immunoassay: a new basis for gestational Down syndrome screening. Clin Chem. 1999;45(12):2109–19.PubMed

97.

Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn. 1987;7(9):623–30.PubMedCrossRef

98.

Jauniaux E, Bao S, Eblen A, Li X, Lei ZM, Meuris S, et al. HCG concentration and receptor gene expression in placental tissue from trisomy 18 and 21. Mol Hum Reprod. 2000;6(1):5–10.PubMedCrossRef

99.

Reynolds T. The triple test as a screening technique for Down syndrome: reliability and relevance. Int J Womens Health. 2010;2:83–8.PubMedCrossRef

100.

Frendo JL, Vidaud M, Guibourdenche J, Luton D, Muller F, Bellet D, et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down’s syndrome. J Clin Endocrinol Metab. 2000;85(10):3700–7.PubMedCrossRef

101.

Massin N, Frendo JL, Guibourdenche J, Luton D, Giovangrandi Y, Muller F et al. Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down’s syndrome. Placenta. 2001;22 Suppl A:S93-7.

102.

Palomaki GE, Knight GJ, Lambert-Messerlian G, Canick JA, Haddow JE. Four years’ experience with an interlaboratory comparison program involving first-trimester markers of Down syndrome. Arch Pathol Lab Med. 2010;134(11):1685–91.PubMed

Title: Extragonadal actions of chorionic gonadotropin
Authors: Prajna Banerjee
Asgerally T. Fazleabas
Publication date: 01-12-2011
Publisher: Springer US
Published in: Reviews in Endocrine and Metabolic Disorders / Issue 4/2011
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-011-9193-1

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2011

Novel pathways in gonadotropin receptor signaling and biased agonism

Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications

Synthesis and secretion of gonadotropins including structure-function correlates

Animal models for aberrations of gonadotropin action

Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials